Navigation Links
Scopolamine: An old drug with new psychiatric applications
Date:2/12/2013

Philadelphia, PA, February 12, 2013 Scopolamine is an anticholinergic drug with many uses. For example, it prevents nausea, vomiting, and motion sickness.

However, scopolamine is re-emerging as an antidepressant, with recent studies showing that scopolamine can rapidly improve mood in depressed patients. In addition, in a new study published in Biological Psychiatry this month by Dr. Moriel Zelikowsky and colleagues at the University of California, Los Angeles, it may also be a possible treatment for anxiety disorders.

Exposure therapy, where the key goal is the elimination of fear through repeated 'safe' exposure to the threat, is commonly employed for the treatment of anxiety disorders. However, its effectiveness is diminished because humans and animals alike tend to be very sensitive to context, causing extinction learning to be dependent on the environment in which it occurs. This makes memories formed during extinction unstable. As a result, extinguished fears commonly return when people put themselves in new situations.

"Current research aimed at treating this problem either employs invasive, untranslatable methods or attempts to strengthen extinction learning rather than prevent relapse," explained senior author Dr. Michael Fanselow.

In an effort to solve this dilemma, Fanselow and his team took a novel theoretical approach. Employing an animal model of exposure therapy, they found they were able to disrupt the rats' contextual processing during extinction using low doses of scopolamine, which blocked the return of fear when the rats were exposed to both the original and a new context.

"This finding provides groundbreaking evidence that changing the nature of extinction learning, rather than its magnitude, can produce profound improvements in the prevention of relapse," added Fanselow.

Scopolamine also slowed the rate of extinction memory formation, which was overcome by adding training sessions. Taken together, these findings indicate that scopolamine may serve as a promising pharmacological adjunct to exposure therapy by improving one's resiliency to environmental changes.

"The emerging new uses for scopolamine are quite promising, although further research is needed," commented Dr. John Krystal, Editor of Biological Psychiatry. "These new data are a wonderful example of the capacity of translational neuroscience approaches to identify new uses for old medications."


'/>"/>
Contact: Rhiannon Bugno
Biol.Psych@utsouthwestern.edu
214-648-0880
Elsevier
Source:Eurekalert

Related medicine news :

1. Symptomatic behaviour in childhood strongly predicts psychiatric treatment as a young adult
2. Psychiatric Patients Often Wait Nearly 12 Hours in ER
3. Bias found in mental health drug research presented at major psychiatric meeting
4. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
5. Children with autism arrive at emergency room for psychiatric crisis 9 times more than peers
6. For Psychiatric Patients, Cancer Is Often Spotted Too Late
7. Protecting psychiatric medical records puts patients at risk of hospitalization
8. Study examines link between incarceration and psychiatric disorders
9. Frontiers publishes systematic review on the effects of yoga on major psychiatric disorders
10. Family practice offers genetic tests to predict effective psychiatric meds, a CAMH study
11. Application Development Firm Anahata Technologies Pty Ltd Announces JavaFX 2.0 as Technology of Choice for Enterprise Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Three Narrow ... Roads” is the creation of published author, Rev. Dr. Burnett King Sr., is currently ... coach and founder of the Faith Track Club, Inc., a track-and-field program geared towards ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin Care Ltd., ... solutions, recently announced the launch of two new skincare products, Prache Antiaging ... alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “We are ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Steve the Snake”: an entertaining and moral-based ... the creation of published author, Harold Flash Haskins Jr., a husband, father and grandfather ... police officer. , “I write moral-based short stories for children and teens. My goal ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... health care organizations and considered extremely effective, very effective, or effective by 85% ... Physician Leadership”. , NEJM Catalyst Insights Reports are based on surveys of the ...
(Date:8/17/2017)... ... August 17, 2017 , ... Industry CEOs, life ... for Anti-Infectives Rx. This off-the-record networking forum of the Boston Biotech Conference series ... School. , Industry leaders and decision makers will discuss issues facing the development ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Calif. , Aug. 15, 2017  AOTI Inc. announced today ... Oxygen Therapy Inc., has recently opened a New York City Office ... ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ) ... by the Accreditation Commission for Health Care (ACHC) under the company,s ... ...
(Date:8/10/2017)... 10, 2017  Physical Rehabilitation Network (PRN), acquired the long-standing ... Lakewood, Colorado . The reputable clinic will continue to ... DPT with his staff of four clinicians. Lipkin received his ... brings over 10 years of experience with a strong background ... PT marks the 10th PRN clinic in and around the ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
Breaking Medicine Technology: